Feasibility and Safety of autoloGous UncondItioneD pEripheral Nerve Tissue Delivery to the Substantia Nigra (GUIDE)
Clinical trial NCT05377281 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05377281
- Sponsor
- Craig van Horne, MD, PhD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-07
- Primary completion
- 2027-06-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.